Suraksha Diagnostic is one of the upcoming IPOs in India. The IPO opens for subscription today, November 29, 2024, and closes on December 3, 2024. The allotment for the Suraksha Diagnostic is likely to be finalised on Wednesday, December 4, 2024. The shares will be listed on BSE and NSE with a tentative listing date set as Friday, December 6, 2024.
Suraksha Diagnostic IPO is a book-built issue of ₹846.25 crore. The issue is completely an offer for sale of 1.92 crore shares. The price band of the IPO is set at ₹420 to ₹441 per share. The minimum lot size for an application is 34 shares. Retail investors are needed to invest a minimum amount of ₹14,994.
As of November 29, 2024, 9:29 AM, Suraksha Diagnostic GMP stands at ₹0.
On Day 1, November 29, 2024, as of 12:10 PM, the IPO was subscribed 0.02 times. The retail category was subscribed 0.04x and the NII category was 0.01x.
Suraksha Diagnostic provides a comprehensive range of pathology and radiology testing services, along with medical consultations, through its extensive network. As of June 30, 2024, the network includes a flagship central reference laboratory, 8 satellite laboratories located within diagnostic centres, and 215 customer touchpoints. These touchpoints comprise 49 diagnostic centres and 166 sample collection centres, primarily franchised, spread across West Bengal, Bihar, Assam, and Meghalaya.
In the three-month period ending June 30, 2024, the company conducted approximately 1.58 million tests, catering to around 0.28 million patients, with 95.34% of its operational revenue derived from Kolkata and the rest of West Bengal. For the fiscal year 2024, Suraksha Diagnostic performed approximately 5.98 million tests, serving 1.14 million patients, with 95.48% of its revenue also generated from its core market of Kolkata and West Bengal.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
